Madam Goh, now 62, had thyroid eye disease (TED), a rare autoimmune disease in which the eye muscles and fatty tissue behind ...

For patients with mild TED, supportive care including ocular surface management offers substantial benefit. Selenium supplementation has also been examined for the treatment of mild, active TED ...

Unintentional weight loss, shakes and tremors, heart palpitations, and heat intolerance are among some of the telltale signs ...

Mahoney said thyroid eye disease is an orbital inflammatory disorder, and a few other conditions mimic its effect on patients, including infectious etiologies, vascular disorders and neoplasms.

Dec 16 (Reuters) - Viridian Therapeutics' (VRDN.O), opens new tab experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging ...

EST Acelyrin (SLRN) sinks 39% to $2.12 after thyroid eye disease data updateStay Ahead of the Market:Discover outperforming stocks and ...

Acelyrin has offered a more detailed look at positive Phase 2 data for its thyroid eye disease drug candidate as it tees up ...

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announces the company’s ...

The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.

Totality of data observed with subcutaneous lonigutamab in Thyroid Eye Disease (TED) patients demonstrate potential for efficacy in line with standard of care and a more favorable safety profile ...

ACELYRIN, INC. (SLRN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Vikram ...